Alex Brittain is the Director of Medical Writing for Early-Phase Immunology at Eli Lilly and Company, a position they have held since 2023. Additionally, Alex serves as the Associate Director of Global Scientific Communications at the same company since 2022.
This person is not in the org chart
This person is not in any teams
This person is not in any offices